View in EDS HTML Full Text PDF Full Text

CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making.

Saved in:
Bibliographic Details
Title: CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making.
Authors: Worst, Thomas S.1 (AUTHOR) thomas.worst@medma.uni-heidelberg.de, Weis, Cleo-Aron2 (AUTHOR), Stöhr, Robert3 (AUTHOR), Bertz, Simone3 (AUTHOR), Eckstein, Markus3 (AUTHOR), Otto, Wolfgang4 (AUTHOR), Breyer, Johannes4 (AUTHOR), Hartmann, Arndt3 (AUTHOR), Bolenz, Christian5 (AUTHOR), Wirtz, Ralph M.6,7 (AUTHOR), Erben, Philipp1 (AUTHOR)
Source: Scientific Reports. 9/26/2018, Vol. 8 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-018-32569-x